BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $103 at Stifel After Roctavian Deep Dive
Tweet Send to a Friend
Stifel analyst Paul Matteis raised the price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $103.00 (from $96.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
